Upcoming AWS Coverage on BeiGene Post-Earnings Results
LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. blog coverage looks at the headline from Lexington based Agenus Inc. (NASDAQ: AGEN) as the Company announced on March 31, 2017, that it is reorganizing its business and operations to focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
One of Agenus’ competitors within the Biotechnology space, BeiGene, Ltd. (NASDAQ: BGNE), reported on March 22, 2017, its business highlights and financial results for Q4 and full year of 2016. AWS will be initiating a research report on BeiGene in the…
Read the full article at: http://finance.yahoo.com/news/blog-coverage-agenus-announced-restructuring-121500958.html